Pzena Investment Management LLC Has $46.48 Million Stake in Varex Imaging $VREX

Pzena Investment Management LLC decreased its position in Varex Imaging (NASDAQ:VREX) by 5.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,989,364 shares of the company’s stock after selling 237,659 shares during the period. Pzena Investment Management LLC owned about 0.10% of Varex Imaging worth $46,476,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in shares of Varex Imaging by 4.4% during the 3rd quarter. Vanguard Group Inc. now owns 2,989,847 shares of the company’s stock valued at $37,074,000 after buying an additional 126,396 shares during the period. Neuberger Berman Group LLC boosted its stake in shares of Varex Imaging by 1.4% during the 3rd quarter. Neuberger Berman Group LLC now owns 1,518,674 shares of the company’s stock valued at $18,810,000 after buying an additional 21,499 shares during the period. Millennium Management LLC boosted its stake in shares of Varex Imaging by 119.8% during the 3rd quarter. Millennium Management LLC now owns 913,169 shares of the company’s stock valued at $11,323,000 after buying an additional 497,650 shares during the period. Assenagon Asset Management S.A. boosted its stake in shares of Varex Imaging by 79.9% during the 4th quarter. Assenagon Asset Management S.A. now owns 532,748 shares of the company’s stock valued at $6,207,000 after buying an additional 236,620 shares during the period. Finally, Jacobs Levy Equity Management Inc. boosted its stake in shares of Varex Imaging by 5.3% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 529,793 shares of the company’s stock valued at $6,569,000 after buying an additional 26,488 shares during the period.

Insider Activity

In other news, Director Jay K. Kunkel sold 4,510 shares of the business’s stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $11.14, for a total transaction of $50,241.40. Following the transaction, the director owned 23,450 shares in the company, valued at approximately $261,233. The trade was a 16.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 4.60% of the company’s stock.

Varex Imaging Stock Performance

Shares of VREX opened at $10.13 on Friday. The company has a market capitalization of $426.47 million, a PE ratio of -5.07 and a beta of 0.96. Varex Imaging has a one year low of $6.76 and a one year high of $14.56. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 1.43. The company’s fifty day moving average price is $10.99 and its 200 day moving average price is $12.03.

Varex Imaging (NASDAQ:VREX) last announced its earnings results on Thursday, May 7th. The company reported $0.21 EPS for the quarter, missing the consensus estimate of $0.22 by ($0.01). Varex Imaging had a positive return on equity of 8.19% and a negative net margin of 9.64%.The firm had revenue of $216.00 million during the quarter, compared to the consensus estimate of $216.92 million. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. As a group, analysts expect that Varex Imaging will post 0.93 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on VREX shares. Jefferies Financial Group reissued a “hold” rating and set a $14.50 target price on shares of Varex Imaging in a research note on Monday, February 2nd. Wall Street Zen lowered shares of Varex Imaging from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Weiss Ratings reissued a “sell (d-)” rating on shares of Varex Imaging in a research note on Friday, March 27th. Zacks Research raised shares of Varex Imaging from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 13th. Finally, B. Riley Financial reaffirmed a “buy” rating on shares of Varex Imaging in a research note on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $16.17.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.